BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24176395)

  • 1. 2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; a new class of potent, selective and orally active glycogen synthase kinase-3β inhibitors.
    Fukunaga K; Uehara F; Aritomo K; Shoda A; Hiki S; Okuyama M; Usui Y; Watanabe K; Yamakoshi K; Kohara T; Hanano T; Tanaka H; Tsuchiya S; Sunada S; Saito K; Eguchi J; Yuki S; Asano S; Tanaka S; Mori A; Yamagami K; Baba H; Horikawa T; Fujimura M
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6933-7. PubMed ID: 24176395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-(4-Pyridyl)pyrimidin-4(3H)-ones as CNS penetrant glycogen synthase kinase-3β inhibitors.
    Uehara F; Shoda A; Aritomo K; Fukunaga K; Watanabe K; Ando R; Shinoda M; Ueno H; Kubodera H; Sunada S; Saito K; Kaji T; Asano S; Eguchi J; Yuki S; Tanaka S; Yoneyama Y; Niwa T
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6928-32. PubMed ID: 24094818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3β inhibitors for Alzheimer's disease.
    Fukunaga K; Sakai D; Watanabe K; Nakayama K; Kohara T; Tanaka H; Sunada S; Nabeno M; Okamoto M; Saito K; Eguchi J; Mori A; Tanaka S; Inazawa K; Horikawa T
    Bioorg Med Chem Lett; 2015 Mar; 25(5):1086-91. PubMed ID: 25655721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel 2-(4-aryl-2-methylpiperazin-1-yl)-pyrimidin-4-ones as glycogen synthase kinase-3β inhibitors.
    Kohara T; Nakayama K; Watanabe K; Kusaka SI; Sakai D; Tanaka H; Fukunaga K; Sunada S; Nabeno M; Saito KI; Eguchi JI; Mori A; Tanaka S; Bessho T; Takiguchi-Hayashi K; Horikawa T
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3733-3738. PubMed ID: 28712706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel 2-(3-phenylpiperazin-1-yl)-pyrimidin-4-ones as glycogen synthase kinase-3β inhibitors.
    Usui Y; Uehara F; Hiki S; Watanabe K; Tanaka H; Shouda A; Yokoshima S; Aritomo K; Adachi T; Fukunaga K; Sunada S; Nabeno M; Saito KI; Eguchi JI; Yamagami K; Asano S; Tanaka S; Yuki S; Yoshii N; Fujimura M; Horikawa T
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3726-3732. PubMed ID: 28712708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 3-benzisoxazolyl-4-indolylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3β.
    Ye Q; Li M; Zhou Y; Pang T; Xu L; Cao J; Han L; Li Y; Wang W; Gao J; Li J
    Molecules; 2013 May; 18(5):5498-516. PubMed ID: 23669633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori filtrate induces Alzheimer-like tau hyperphosphorylation by activating glycogen synthase kinase-3β.
    Wang XL; Zeng J; Yang Y; Xiong Y; Zhang ZH; Qiu M; Yan X; Sun XY; Tuo QZ; Liu R; Wang JZ
    J Alzheimers Dis; 2015; 43(1):153-65. PubMed ID: 25079798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
    Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
    J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening.
    Zhang P; Hu HR; Huang ZH; Lei JY; Chu Y; Ye DY
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7232-6. PubMed ID: 23099099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bip enhanced the association of GSK-3β with tau during ER stress both in vivo and in vitro.
    Liu ZC; Fu ZQ; Song J; Zhang JY; Wei YP; Chu J; Han L; Qu N; Wang JZ; Tian Q
    J Alzheimers Dis; 2012; 29(4):727-40. PubMed ID: 22460328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta with good brain permeability.
    Saitoh M; Kunitomo J; Kimura E; Iwashita H; Uno Y; Onishi T; Uchiyama N; Kawamoto T; Tanaka T; Mol CD; Dougan DR; Textor GP; Snell GP; Takizawa M; Itoh F; Kori M
    J Med Chem; 2009 Oct; 52(20):6270-86. PubMed ID: 19775160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of Novel Pyrimidin-4-One Bearing Piperazine Ring-Based Amides as Glycogen Synthase Kinase-3β Inhibitors with Antidepressant Activity.
    Khan I; Tantray MA; Hamid H; Alam MS; Kalam A; Shaikh F; Shah A; Hussain F
    Chem Biol Drug Des; 2016 May; 87(5):764-72. PubMed ID: 26714831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LiCl attenuates thapsigargin-induced tau hyperphosphorylation by inhibiting GSK-3β in vivo and in vitro.
    Fu ZQ; Yang Y; Song J; Jiang Q; Lin ZC; Wang Q; Zhu LQ; Wang JZ; Tian Q
    J Alzheimers Dis; 2010; 21(4):1107-17. PubMed ID: 21504119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase-3beta activation.
    Zhang YJ; Xu YF; Liu YH; Yin J; Wang JZ
    FEBS Lett; 2005 Nov; 579(27):6230-6. PubMed ID: 16253246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The marine natural-derived inhibitors of glycogen synthase kinase-3beta phenylmethylene hydantoins: In vitro and in vivo activities and pharmacophore modeling.
    Khanfar MA; Asal BA; Mudit M; Kaddoumi A; El Sayed KA
    Bioorg Med Chem; 2009 Aug; 17(16):6032-9. PubMed ID: 19616957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.
    Koh SH; Noh MY; Kim SH
    Brain Res; 2008 Jan; 1188():254-62. PubMed ID: 18031715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of potent and bioavailable GSK-3beta inhibitors.
    Gong L; Hirschfeld D; Tan YC; Heather Hogg J; Peltz G; Avnur Z; Dunten P
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1693-6. PubMed ID: 20138512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cells.
    Hu M; Waring JF; Gopalakrishnan M; Li J
    J Neurochem; 2008 Aug; 106(3):1371-7. PubMed ID: 18485099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and evaluation of 3-aryl-4-pyrrolyl-maleimides as glycogen synthase kinase-3β inhibitors.
    Ye Q; Li M; Zhou YB; Cao JY; Xu L; Li YJ; Han L; Gao JR; Hu YZ; Li J
    Arch Pharm (Weinheim); 2013 May; 346(5):349-58. PubMed ID: 23585245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.
    An WL; Bjorkdahl C; Liu R; Cowburn RF; Winblad B; Pei JJ
    J Neurochem; 2005 Mar; 92(5):1104-15. PubMed ID: 15715661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.